Abstract
A prospective, randomized trial was conducted to compare the efficacy of aztreonam, a monobactam, antibiotic, and gentamicin in the treatment of serious urinary tract infections. Fifty-five patients with a suspected or confirmed infection were randomized, 28 received aztreonam and 27 received gentamicin. Both antibiotics had a high clinical response rate (aztreonam 92%, gentamicin 85%). However, the duration of treatment was significantly shorter (p=0.037, Wilcoxon Rank Sum Test) when aztreonam was used. There were no cases of toxicity with either antibiotic but 5 patients who received gentamicin required dose alteration.
Aztreonam is well tolerated and is no less effective than gentamicin in the treatment of urinary tract infections and has advantages in convenience of use and duration of treatment.
Similar content being viewed by others
References
Lindsay, G., Woods, P. B.: Susceptibility of 90,000 Gram negative isolates to Aztreonam and other antibiotics. 5th Mediterranean Congress of Chemotherapy 1986, Book of Abstracts, pp. 98–321.
Bush, K., Sykes, R. B.: Interaction of beta-lactam antibiotics with beta-lactamases as a cause for resistance. In: Bryan, L. E. (ed.): Antimicrobial Drug Resistance. Academic Press, New York 1984, pp. 1–31.
Farmer, T. H., Reading, C.: Induction of the beta-lactamases of a strain of Pseudomonas aeruginosa, Morganella morganii and Enterobacter cloacae.J. Antimicrob. Chemother., 19, 401 (1987).
Wiser, R., Ashby, J. P., Piddock, L. J. V.: Induction of beta-lactamases in Gram negative bacilli.J. Antimicrob. Chemother., 20, 767 (1987).
Borriello, S. P.: Effects of antimicrobials on normal gut flora and function. In: Howard, A. J. (ed.): Royal Society of Medicine International Congress Symposium Series 1988, 139, pp. 55–59.
Henry, S. A., Bendush, C. B.: Aztreonam: Worldwide overview of the treatment of patients with Gram negative infections.Am. J. Med., 78 (Suppl. 2A), 57 (1985).
Bendush, C. B., Weber, R.: Tobramycin sulphate: A summary of worldwide experience from clinical trials.J. Infect. Dis., 134 (Suppl.), 30 (1976).
Averiei, G. M., Falco, F. G., Smith, H. M.: Clinical research experience with gentamicin: incidence of adverse reactions.Med. J. Aust., 1 (Suppl.), 30 (1970).
Platt, R.: Quantitative definition of bacteriuria (Infectious Diseases Symposium).Am. J. Med., 75, 44 (1983).
Stamm, W. E., Counts, G. W., Running, K. R., Finn, S., Turck, M., Holmes, K. K.: Diagnosis of coliform infection in acutely dysuric women.N. Engl. J. Med., 307, 463 (1982).
Stamm, W. E.: Measurement of pyuria and its relation to bacteriuria (Infectious Diseases Symposium).Am. J. Med., 75, 53 (1983).
Musher, D. M., Thoransteinsson, S. B., Airola, V. M.: Quantitative urinanalysis.JAMA, 236, 2069 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waller, D.A., Kendall, S.W.H. & Whelan, P. A comparative trial of aztreonam versus gentamicin in the treatment of urinary tract infections. International Urology and Nephrology 24, 221–227 (1992). https://doi.org/10.1007/BF02549528
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02549528